You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 076094


✉ Email this page to a colleague

« Back to Dashboard


NDA 076094 describes PERGOLIDE MESYLATE, which is a drug marketed by Ivax Sub Teva Pharms and Strides Pharma and is included in two NDAs. Additional details are available on the PERGOLIDE MESYLATE profile page.

The generic ingredient in PERGOLIDE MESYLATE is pergolide mesylate. There are four drug master file entries for this compound. Additional details are available on the pergolide mesylate profile page.
Summary for 076094
Tradename:PERGOLIDE MESYLATE
Applicant:Ivax Sub Teva Pharms
Ingredient:pergolide mesylate
Patents:0
Medical Subject Heading (MeSH) Categories for 076094

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 0.05MG BASE
Approval Date:Sep 4, 2003TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 0.25MG BASE
Approval Date:Sep 4, 2003TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Sep 4, 2003TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.